These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 28466255)
1. Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination. Bihler K; Kress E; Esser S; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Brandenburg LO J Mol Neurosci; 2017 Jun; 62(2):232-243. PubMed ID: 28466255 [TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination. Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338 [TBL] [Abstract][Full Text] [Related]
3. Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model. Le Blon D; Guglielmetti C; Hoornaert C; Quarta A; Daans J; Dooley D; Lemmens E; Praet J; De Vocht N; Reekmans K; Santermans E; Hens N; Goossens H; Verhoye M; Van der Linden A; Berneman Z; Hendrix S; Ponsaerts P J Neuroinflammation; 2016 Nov; 13(1):288. PubMed ID: 27829467 [TBL] [Abstract][Full Text] [Related]
4. CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system. Krauthausen M; Saxe S; Zimmermann J; Emrich M; Heneka MT; Müller M J Neuroinflammation; 2014 Jun; 11():109. PubMed ID: 24930935 [TBL] [Abstract][Full Text] [Related]
5. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain. Azami Tameh A; Clarner T; Beyer C; Atlasi MA; Hassanzadeh G; Naderian H Ann Anat; 2013 Oct; 195(5):415-23. PubMed ID: 23711509 [TBL] [Abstract][Full Text] [Related]
6. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation. Petković F; Campbell IL; Gonzalez B; Castellano B Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761 [TBL] [Abstract][Full Text] [Related]
7. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia. Nomura T; Bando Y; You H; Tanaka T; Yoshida S Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408 [TBL] [Abstract][Full Text] [Related]
8. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination. Yu H; Wu M; Lu G; Cao T; Chen N; Zhang Y; Jiang Z; Fan H; Yao R Brain Res; 2018 Jan; 1678():75-84. PubMed ID: 29038005 [TBL] [Abstract][Full Text] [Related]
9. Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination. Jia Y; Li H; Bao H; Zhang D; Feng L; Xiao Y; Zhu K; Hou Y; Luo S; Zhang Y; Xiao L; Chen X; Zhou J; Wang C; Wang G; Yu H; Xiao C; Du J Int Immunopharmacol; 2019 Oct; 75():105777. PubMed ID: 31357085 [TBL] [Abstract][Full Text] [Related]
10. Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier. Janssen K; Rickert M; Clarner T; Beyer C; Kipp M Mol Neurobiol; 2016 Apr; 53(3):1551-1564. PubMed ID: 25663168 [TBL] [Abstract][Full Text] [Related]
12. The crucial role of Erk2 in demyelinating inflammation in the central nervous system. Okazaki R; Doi T; Hayakawa K; Morioka K; Imamura O; Takishima K; Hamanoue M; Sawada Y; Nagao M; Tanaka S; Ogata T J Neuroinflammation; 2016 Sep; 13(1):235. PubMed ID: 27596241 [TBL] [Abstract][Full Text] [Related]
13. Microglial recruitment, activation, and proliferation in response to primary demyelination. Remington LT; Babcock AA; Zehntner SP; Owens T Am J Pathol; 2007 May; 170(5):1713-24. PubMed ID: 17456776 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model. Tejedor LS; Wostradowski T; Gingele S; Skripuletz T; Gudi V; Stangel M J Mol Neurosci; 2017 Apr; 61(4):479-488. PubMed ID: 28124770 [TBL] [Abstract][Full Text] [Related]
15. TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis. Sághy É; Sipos É; Ács P; Bölcskei K; Pohóczky K; Kemény Á; Sándor Z; Szőke É; Sétáló G; Komoly S; Pintér E Glia; 2016 Dec; 64(12):2166-2180. PubMed ID: 27568827 [TBL] [Abstract][Full Text] [Related]
16. Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model. Aryanpour R; Pasbakhsh P; Zibara K; Namjoo Z; Beigi Boroujeni F; Shahbeigi S; Kashani IR; Beyer C; Zendehdel A Int Immunopharmacol; 2017 Oct; 51():131-139. PubMed ID: 28830026 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages. Guglielmetti C; Le Blon D; Santermans E; Salas-Perdomo A; Daans J; De Vocht N; Shah D; Hoornaert C; Praet J; Peerlings J; Kara F; Bigot C; Mai Z; Goossens H; Hens N; Hendrix S; Verhoye M; Planas AM; Berneman Z; van der Linden A; Ponsaerts P Glia; 2016 Dec; 64(12):2181-2200. PubMed ID: 27685637 [TBL] [Abstract][Full Text] [Related]
18. The cuprizone model: regional heterogeneity of pathology. Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688 [TBL] [Abstract][Full Text] [Related]
19. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. Tanaka T; Murakami K; Bando Y; Yoshida S J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102 [TBL] [Abstract][Full Text] [Related]
20. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. Irvine KA; Blakemore WF J Neuroimmunol; 2006 Jun; 175(1-2):69-76. PubMed ID: 16626812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]